HBM BioVentures
As a venture capital company, HBM BioVentures is invested globally in some 40 mature emerging companies in the biotechnology/human medicine, diagnostics and medical technology sectors. The primary products of HBM BioVentures’ portfolio companies are either at an advanced stage of development or already available on the market. The company focuses on unquoted emerging companies, with two-thirds are invested in private companies that offer high value creation potential. This has enabled HBM BioVentures to carve out a unique and distinctive market position. HBM BioVentures has a broad shareholder base and is listed on the SIX Swiss Exchange (ticker: HBMN).
Recent Milestones
Investments
Videos
Sources
-
PTC Therapeutics Completes $30M Financing (finsmes.com)
[edit]
-
Probiodrug Raises €15M in Funding (finsmes.com)
[edit]
-
Ellipse Technologies Closes $17.6M Series C Private Equity Financing (finsmes.com)
[edit]
-
Delenex Therapeutics Raises $19.3M (finsmes.com)
[edit]
-
Vivacta Closes £4M Financing Round (finsmes.com)
[edit]
-
mtm laboratories Raises Additional €7M in Series C Financing (finsmes.com)
[edit]
-
Cylene Pharmaceuticals Gets $12M (socaltech.com)
[edit]
-
Nereus Pharmaceuticals, Inc.: Series E $20M (onbiovc.com)
[edit]
-
Nabriva Therapeutics, AG: Series B $22M (onbiovc.com)
[edit]
-
PTC Therapeutics Raises 50M in Equity Financing (finsmes.com)
[edit]
-
Ophthotech nabs $30M round to fund AMD trial (fiercebiotech.com)
[edit]
-
Probiodrug Closes Series B Financing Round exceeding EUR 36 Million (US$54 Million) (probiodrug.de)
[edit]
-
Kolltan Pharmaceuticals, Inc.: Series A $5M (onbiovc.com)
[edit]
-
mtm laboratories Extends Series C Financing Round by EUR 7 Million Bringing Total to EUR 39 Million (USD 57 Million) (mtmlabs.com)
[edit]
-
Lux Biosciences scores $50M Series B for eye cure (venturebeat.com)
[edit]
-
Zosano Pharma, Inc.: Series B $30M (onbiovc.com)
[edit]
-
ESBATech rounds up $22M in second round (fiercebiotech.com)
[edit]
-
Pelikan Tech to push “finger friendly†diabetes testing (venturebeat.com)
[edit]
-
Zosano Pharma, Inc. Announces Funding Close Totaling $90 Million (zosanopharma.com)
[edit]
-
Sloning BioTechnology GmbH Raised € 4.7m in a First Closing of a Series E Equity Financing Round (sloning.com)
[edit]
-
Adnexus Therapeutics Raises $15.5 Million in Series C Funding (adnexustx.com)
[edit]
-
Agensys Raises $41 Million (agensys.com)
[edit]
-
BaroFold pulls in $12M for protein-refolding technology (venturebeat.com)
[edit]
-
ChemoCentryx, autoimmune disease drug co., raises $29.84M (deals.venturebeat.com)
[edit]
-
Cylene Pharmaceuticals Closes $44 Million Series C Financing (rctech.com)
[edit]
-
ChemoCentryx Completes Series C Financing (chemocentryx.com)
[edit]
-
ESBATech Closes USD 41M Series B Venture Financing (esbatech.com)
[edit]
-
GENIZON SECURES $12 MILLION IN SECURED CONVERTIBLE DEBENTURES (genizon.com)
[edit]
-
PTC THERAPEUTICS RAISES $26.6 MILLION IN PRIVATE PLACEMENT FINANCING (ptct.client.shareholder.com)
[edit]
-
Mpex Pharmaceuticals Closes $32 Million Series B Financing (mpexpharma.com)
[edit]
-
Sloning BioTechnology closes new round of financing (sloning.com)
[edit]
-
ChemoCentryx Raises $33 Million in Private Financing (chemocentryx.com)
[edit]
-
History of mtm laboratories AG (mtmlabs.com)
[edit]
-
Broncus Technologies lines up venture debt financing for emphysema treatment (venturebeat.com)
[edit]